Pharmaceuticals, Biotechnology and Life Sciences
The device and new delivery system combine proven conformability with enhanced placement control to optimize TEVAR outcomes in even complex…
HOUSTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/SpinalCyte?src=hash" target="_blank"gt;#SpinalCytelt;/agt;–SpinalCyte, LLC, a clinical stage regenerative medicine company focused on regrowth of the spinal disc using Human…
Re-Opening the Former WalMart Super-Center will Centralize Manufacturing, Expand Warehousing CLEVELAND–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24IVST&src=ctag" target="_blank"gt;$IVSTlt;/agt; lt;a href="https://twitter.com/hashtag/growth?src=hash" target="_blank"gt;#growthlt;/agt;–Innovest Global Inc. (OTC…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global radiodermatitis treatment market is expected to post a CAGR of more than 4% during the…
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE:AMRX) today announced that members of management will participate in a fireside chat at the…
BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE:AMRX) today announced that members of management will participate in a fireside chat at the…
-Multi-year collaboration leveraging Kymera’s proprietary targeted protein degradation platform to develop novel medicines- -Kymera to receive $70 million upfront, including…
New Company and Collaboration To Develop Novel Therapeutics Including Vonoprazan for the Treatment of Acid-Related Disorders in North America and…
Mavorixafor selected for LLS’s Therapy Acceleration Program® (TAP) CAMBRIDGE, Mass. & RYE BROOK, N.Y.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq:XFOR), a clinical-stage…
Alliance will Utilize Technology from Applied DNA Sciences in ETCH biotrace™ to Secure Supply Chains STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA…